NYSE:AAC - Ares Acquisition Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$9.91
▼ -0.04 (-0.40%)
Get New Ares Acquisition Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AAC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AAC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Ares Acquisition in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $9.91.
N/A
The current consensus among 0 investment analysts is to n/a stock in Ares Acquisition. This rating has held steady since July 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/13/2019Raymond JamesDowngradeOutperform ➝ Market PerformMedium
i
4/18/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$7.00 ➝ $5.00Low
i
11/7/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$4.00High
i
Rating by J. France at Cantor Fitzgerald
10/16/2018Raymond JamesLower Price TargetOutperform ➝ Outperform$14.00 ➝ $12.00High
i
5/2/2018Cantor FitzgeraldReiterated RatingBuy$14.00High
i
1/5/2018Cantor FitzgeraldReiterated RatingBuy$14.00High
i
Rating by J. France at Cantor Fitzgerald
11/16/2017Cantor FitzgeraldReiterated RatingBuy$14.00N/A
i
Rating by J. France at Cantor Fitzgerald
11/3/2017Raymond JamesUpgradeMkt Perform ➝ OutperformN/A
i
11/3/2017UBS GroupUpgradeMarket Perform ➝ OutperformN/A
i
11/1/2017Cantor FitzgeraldReiterated RatingBuy$14.00N/A
i
Rating by J. France at Cantor Fitzgerald
9/27/2017Cantor FitzgeraldReiterated RatingBuy$14.00Low
i
Rating by J. France at Cantor Fitzgerald
9/13/2017Cantor FitzgeraldReiterated RatingOverweight$11.00 ➝ $14.00High
i
Rating by J. France at Cantor Fitzgerald
8/9/2017Cantor FitzgeraldInitiated CoverageOverweight$11.00Medium
i
Rating by J. France at Cantor Fitzgerald
5/30/2017MizuhoLower Price TargetNeutral ➝ Neutral$9.00 ➝ $6.00High
i
11/16/2016MizuhoUpgradeUnderperform ➝ Neutral$9.00N/A
i
Rating by Ann Hynes at Mizuho
11/9/2016MizuhoDowngradeNeutral ➝ Underperform$6.00N/A
i
Rating by Ann Hynes at Mizuho
11/3/2016UBS GroupDowngradeStrong-Buy ➝ Market PerformN/A
i
11/3/2016Raymond JamesDowngradeStrong-Buy ➝ Market PerformN/A
i
11/3/2016MizuhoDowngradeBuy ➝ Neutral$26.00 ➝ $14.00N/A
i
Rating by Ann Hynes at Mizuho
8/15/2016Raymond JamesUpgradeOutperform ➝ Strong-Buy$29.00N/A
i
8/15/2016CitigroupUpgradeOutperform ➝ Strong-Buy$27.00 ➝ $29.00N/A
i
8/15/2016UBS GroupUpgradeOutperform ➝ Strong-BuyN/A
i
7/18/2016MizuhoReiterated RatingBuy$24.00 ➝ $26.00N/A
i
Rating by Ann Hynes at Mizuho
6/16/2016MizuhoReiterated RatingBuy$24.00N/A
i
5/25/2016MizuhoUpgradeNeutral ➝ Buy$24.00N/A
i
4/18/2016Avondale PartnersReiterated RatingMarket OutperformN/A
i
Rating by P. Torch at Avondale Partners
(Data available from 4/14/2016 forward)
Ares Acquisition logo
Ares Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Read More

Today's Range

Now: $9.91
$9.90
$9.99

50 Day Range

MA: $0.45
$0.45
$0.48

52 Week Range

Now: $9.91
$0.32
$6.90

Volume

126,628 shs

Average Volume

306,774 shs

Market Capitalization

$249.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Ares Acquisition?

The following Wall Street analysts have issued research reports on Ares Acquisition in the last twelve months:
View the latest analyst ratings for AAC.

What is the current price target for Ares Acquisition?

0 Wall Street analysts have set twelve-month price targets for Ares Acquisition in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ares Acquisition in the next year.
View the latest price targets for AAC.

What is the current consensus analyst rating for Ares Acquisition?

Ares Acquisition currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AAC.

What other companies compete with Ares Acquisition?

Other companies that are similar to Ares Acquisition include Hanger, Aesthetic Medical International Holdings Group, IMAC, BioCorRx, AAC and Ceres Ventures.

How do I contact Ares Acquisition's investor relations team?

Ares Acquisition's physical mailing address is 200 POWELL PLACE, BRENTWOOD TN, 37027. The company's listed phone number is 615-732-1231 and its investor relations email address is [email protected] The official website for Ares Acquisition is www.americanaddictioncenters.org.